GL1X · GenesisL1 explorer

MolNFT v1 · #147802 · protein

Crystal structure of thrombin in complex with a novel glucose- conjugated potent inhibitor

6EO8: “Crystal structure of thrombin in complex with a novel glucose- conjugated potent inhibitor”. X-ray diffraction, 1 ligand (2FN). MolNFT v1 #147802 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6EO8
Type
protein
Length
283 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P00734, P09945
Ligands
2FN

Structure

x-ray diffraction · 3 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
L—protein26—P00734
H—protein247—P00734
I—protein10—P09945

Ligands and binding sites

  • 2FN · N-(2-{[5-(5-chlorothiophen-2-yl)-1,2-oxazol-3-yl]methoxy}-6-[3-(beta-D-glucopyranosyloxy) propoxy]phenyl)-1-(propan-2-yl)piperidine-4-carboxamide · ligand · chains H
  • DMS · Dimethyl sulfoxide · additive · 6 copies · chains L, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6EO8 · Crystal structure of thrombin in complex with a novel glucose-conjugated potent inhibitor · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.